As an international pharmaceutical company specialized in ophthalmology, Laboratoires Théa operates in a highly regulated environment where patient safety, quality standards, and continuity of care are paramount. Any change in materials, processes, or suppliers must therefore be carefully assessed and implemented progressively.
Aware of the environmental challenges facing the healthcare sector, Théa integrates environmental considerations into its activities while operating within strict regulatory, technical and safety constraints. These considerations are progressively incorporated into the design, production and delivery of treatments.
In this context, Théa has defined a structured roadmap aimed at reducing carbon emissions across its operations and value chain. This approach is designed to align with the global climate objective of carbon neutrality by 2045 and to support a step-by-step reduction of emissions over time.